Retrospective Study in a NSCLC M+ p

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

187 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-03-31

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a national, multicentre, non-interventional, retrospective study to be carried out in the oncology settings of approximately 15-20 Spanish hospitals.

At each participant hospital, all patients recently diagnosed with advanced EGFR mutated NSCLC (both newly or with recurrent disease , without previous treatment for metastatic disease) from April 2010 to December 2011 will be included as study population. Information about the follow-up of the patients during a minimum of 12 months after diagnosis will be collected.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients

NCT01717105

Metastatic Non-Small-Cell Lung Cancer

UNKNOWN

Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

NCT01081496

Non Small Cell Lung Cancer

COMPLETED

Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium

NCT03761901

Carcinoma, Non-Small-Cell Lung

COMPLETED

A Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 Insertion

NCT05419700

Non-small Cell Lung Cancer (NSCLC)

COMPLETED

Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients

NCT03721289

Carcinoma, Non-Small-Cell Lung

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Observational retrospective study to describe the management of advanced or metastatic EGFR mutated non-small cell lung cancer patients in Spain

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

EGFR Mutated Non-small Cell Lung Cancer Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically or cytologically confirmed newly locally advanced or metastatic NSCLC (stage IIIB/IV)
* Confirmed EGFR mutation by a validated test
* Availability of medical record

Exclusion Criteria

* Participating on a blinded randomized clinical trial at any time during the study period
* Pregnant women (due to they do not reflect daily clinical practice)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No